Literature DB >> 21769160

Using Randomization Tests to Preserve Type I Error With Response-Adaptive and Covariate-Adaptive Randomization.

Richard Simon1, Noah Robin Simon.   

Abstract

We demonstrate that clinical trials using response adaptive randomized treatment assignment rules are subject to substantial bias if there are time trends in unknown prognostic factors and standard methods of analysis are used. We develop a general class of randomization tests based on generating the null distribution of a general test statistic by repeating the adaptive randomized treatment assignment rule holding fixed the sequence of outcome values and covariate vectors actually observed in the trial. We develop broad conditions on the adaptive randomization method and the stochastic mechanism by which outcomes and covariate vectors are sampled that ensure that the type I error is controlled at the level of the randomization test. These conditions ensure that the use of the randomization test protects the type I error against time trends that are independent of the treatment assignments. Under some conditions in which the prognosis of future patients is determined by knowledge of the current randomization weights, the type I error is not strictly protected. We show that response-adaptive randomization can result in substantial reduction in statistical power when the type I error is preserved. Our results also ensure that type I error is controlled at the level of the randomization test for adaptive stratification designs used for balancing covariates.

Entities:  

Year:  2011        PMID: 21769160      PMCID: PMC3137591          DOI: 10.1016/j.spl.2010.12.018

Source DB:  PubMed          Journal:  Stat Probab Lett        ISSN: 0167-7152            Impact factor:   0.870


  6 in total

Review 1.  Adaptive treatment assignment methods and clinical trials.

Authors:  R Simon
Journal:  Biometrics       Date:  1977-12       Impact factor: 2.571

2.  Minimization: a new method of assigning patients to treatment and control groups.

Authors:  D R Taves
Journal:  Clin Pharmacol Ther       Date:  1974-05       Impact factor: 6.875

3.  Extracorporeal circulation in neonatal respiratory failure: a prospective randomized study.

Authors:  J H Ware; M F Epstein
Journal:  Pediatrics       Date:  1985-11       Impact factor: 7.124

4.  Sequential treatment assignment with balancing for prognostic factors in the controlled clinical trial.

Authors:  S J Pocock; R Simon
Journal:  Biometrics       Date:  1975-03       Impact factor: 2.571

Review 5.  A group sequential, response-adaptive design for randomized clinical trials.

Authors:  Theodore G Karrison; Dezheng Huo; Rick Chappell
Journal:  Control Clin Trials       Date:  2003-10

Review 6.  The use of response-adaptive designs in clinical trials.

Authors:  W F Rosenberger; J M Lachin
Journal:  Control Clin Trials       Date:  1993-12
  6 in total
  16 in total

1.  Cross-Linking-Assisted Infection Reduction: A Randomized Clinical Trial Evaluating the Effect of Adjuvant Cross-Linking on Outcomes in Fungal Keratitis.

Authors:  N Venkatesh Prajna; Naveen Radhakrishnan; Prajna Lalitha; Ariana Austin; Kathryn J Ray; Jeremy D Keenan; Travis C Porco; Thomas M Lietman; Jennifer Rose-Nussbaumer
Journal:  Ophthalmology       Date:  2019-09-04       Impact factor: 12.079

2.  Adaptive Clinical Trials: Advantages and Disadvantages of Various Adaptive Design Elements.

Authors:  Edward L Korn; Boris Freidlin
Journal:  J Natl Cancer Inst       Date:  2017-06-01       Impact factor: 13.506

3.  Managing competing demands in the implementation of response-adaptive randomization in a large multicenter phase III acute stroke trial.

Authors:  Wenle Zhao; Valerie Durkalski
Journal:  Stat Med       Date:  2014-05-22       Impact factor: 2.373

4.  Improving efficiency and reducing costs: Design of an adaptive, seamless, and enriched pragmatic efficacy trial of an online asthma management program.

Authors:  Mei Lu; Dennis R Ownby; Edward Zoratti; Douglas Roblin; Dayna Johnson; Christine Cole Johnson; Christine L M Joseph
Journal:  Contemp Clin Trials       Date:  2014-03-06       Impact factor: 2.226

5.  Time-trend impact on treatment estimation in two-arm clinical trials with a binary outcome and Bayesian response adaptive randomization.

Authors:  Yunyun Jiang; Wenle Zhao; Valerie Durkalski-Mauldin
Journal:  J Biopharm Stat       Date:  2019-04-24       Impact factor: 1.051

6.  Stratification and partial ascertainment of biomarker value in biomarker-driven clinical trials.

Authors:  Richard Simon
Journal:  J Biopharm Stat       Date:  2014       Impact factor: 1.051

7.  Randomization-based inference for Bernoulli trial experiments and implications for observational studies.

Authors:  Zach Branson; Marie-Abèle Bind
Journal:  Stat Methods Med Res       Date:  2018-02-16       Impact factor: 3.021

8.  Response-adaptive designs for binary responses: How to offer patient benefit while being robust to time trends?

Authors:  Sofía S Villar; Jack Bowden; James Wason
Journal:  Pharm Stat       Date:  2017-12-19       Impact factor: 1.894

9.  Discussion on "Improving precision and power in randomized trials for COVID-19 treatments using covariate adjustment for binary, ordinal, and time-to-event outcomes".

Authors:  Michael A Proschan
Journal:  Biometrics       Date:  2021-06-09       Impact factor: 1.701

10.  Unbiased estimation for response adaptive clinical trials.

Authors:  Jack Bowden; Lorenzo Trippa
Journal:  Stat Methods Med Res       Date:  2015-08-11       Impact factor: 3.021

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.